Advertisement

Diabetologia

, Volume 57, Issue 10, pp 2038–2047 | Cite as

Effects of calcium–vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial

  • Marjan Tabesh
  • Leila Azadbakht
  • Elham Faghihimani
  • Maryam Tabesh
  • Ahmad EsmaillzadehEmail author
Article

Abstract

Aims/hypothesis

This study was performed to assess the effects of vitamin D and calcium supplementation on the metabolic profiles of vitamin D insufficient persons with type 2 diabetes.

Methods

In a parallel designed randomised placebo-controlled clinical trial, a total of 118 non-smoker individuals with type 2 diabetes and insufficient 25-hydroxyvitamin D, aged >30 years, were recruited from the Isfahan Endocrine and Metabolism Research Centre. Participants were randomly assigned to four groups receiving: (1) 50,000 U/week vitamin D + calcium placebo; (2) 1,000 mg/day calcium + vitamin D placebo; (3) 50,000 U/week vitamin D + 1,000 mg/day calcium; or (4) vitamin D placebo + calcium placebo for 8 weeks. A study technician carried out the random allocations using a random numbers table. All investigators, participants and laboratory technicians were blinded to the random assignments. All participants provided 3 days of dietary records and 3 days of physical activity records throughout the intervention. Blood samples were taken to quantify glycaemic and lipid profiles at study baseline and after 8 weeks of intervention.

Results

30 participants were randomised in each group. During the intervention, one participant from the calcium group and one from the vitamin D group were excluded because of personal problems. Calcium–vitamin D co-supplementation resulted in reduced serum insulin (changes from baseline: −14.8 ± 3.9 pmol/l, p = 0.01), HbA1c [−0.70 ± 0.19% (−8.0 ± 0.4 mmol/mol), p = 0.02], HOMA-IR (−0.46 ± 0.20, p = 0.001), LDL-cholesterol (−10.36 ± 0.10 mmol/l, p = 0.04) and total/HDL-cholesterol levels (−0.91 ± 0.16, p = 0.03) compared with other groups. We found a significant increase in QUICKI (0.025 ± 0.01, p = 0.004), HOMA of beta cell function (HOMA-B; 11.8 ± 12.17, p = 0.001) and HDL-cholesterol (0.46 ± 0.05 mmol/l, p = 0.03) in the calcium–vitamin D group compared with others.

Conclusions/interpretation

Joint calcium and vitamin D supplementation might improve the glycaemic status and lipid profiles of vitamin D insufficient people with type 2 diabetes.

Trial registration: ClinicalTrials.gov NCT01662193

Funding: Clinical Research Council, Isfahan University of Medical Sciences, Isfahan, Iran

Keywords

Calcium Glycaemia Metabolic profiles Type 2 diabetes Vitamin D 

Abbreviations

25(OH)D

25-Hydroxyvitamin D

FPG

Fasting plasma glucose

HOMA-B

HOMA of beta cell function

IEMRC

Isfahan Endocrine and Metabolism Research Center

METs

Metabolic equivalents

Notes

Acknowledgements

The authors would like to thank the Food Security Research Center of Isfahan University of Medical Sciences. This paper is based on an MSc thesis (190136) from Isfahan University of Medical Sciences. Marjan Tabesh was the author of the MSc thesis.

Funding

The study was funded by the Clinical Research Council, Isfahan University of Medical Sciences, Isfahan, Iran

Duality of interest

The authors declare that there is no duality of interest associated with this manuscript.

Contribution statement

Marj. T contributed to conception, design, statistical analyses, data interpretation, and manuscript drafting for this study. Marj. T, Mary. T, LA and EF contributed to the data collection and manuscript drafting. All authors approved the final manuscript for submission. AE is the guarantor of this work.

References

  1. 1.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281PubMedCrossRefGoogle Scholar
  2. 2.
    Saneei P, Salehi-Abargouei A, Esmaillzadeh A (2013) Serum 25-hydroxyvitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev 14:393–404PubMedCrossRefGoogle Scholar
  3. 3.
    Ganji V, Zhang X, Shaikh N, Tangpricha V (2011) Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001–2006. Am J Clin Nutr 94:225–233PubMedCrossRefGoogle Scholar
  4. 4.
    Anagnostis P, Athyros VG, Adamidou F, Florentin M, Karagiannis A (2010) Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk? Curr Vasc Pharmacol 8:720–730PubMedCrossRefGoogle Scholar
  5. 5.
    Harris SS (2011) Does vitamin D deficiency contribute to increased rates of cardiovascular disease and type 2 diabetes in African Americans? Am J Clin Nutr 93:1175–1178CrossRefGoogle Scholar
  6. 6.
    Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC et al (2010) Association of vitamin D with insulin resistance and cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 33:1379–1381PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J, Elliott P (1996) Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med 124:825–831PubMedCrossRefGoogle Scholar
  8. 8.
    Gagnon C, Lu ZX, Magliano DJ et al (2011) Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years. Diabetes Care 34:1133–1138PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10:185–197PubMedCrossRefGoogle Scholar
  10. 10.
    Mitri J, Dawson-Hughes B, Hu FB, Pittas AG (2011) Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94:486–494PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Pittas AG, Harris SS, Stark PC, Dawson-Hughes B (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non diabetic adults. Diabetes Care 30:980–986PubMedCrossRefGoogle Scholar
  12. 12.
    Major GC, Alarie F, Dore J, Phouttama S, Tremblay A (2007) Supplementation with calcium, vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 85:54–59PubMedGoogle Scholar
  13. 13.
    Rajpathak SN, Xue X, Wassertheil-Smoller S, Horn LV, Robinson JG, Liu S et al (2010) Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women’s Health Initiative. Am J Clin Nutr 91:894–899PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P et al (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115:846–854PubMedCrossRefGoogle Scholar
  15. 15.
    Gannage-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R (2003) Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest 26:748–753PubMedCrossRefGoogle Scholar
  16. 16.
    Noda M, Mizoue T (2010) Relation between dietary calcium and vitamin D and risk of diabetes and cancer: a review and perspective. JCMD 1:55–60Google Scholar
  17. 17.
    Al-Daghri NM, Alkharfy KM, Al-Othman A et al (2012) Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol 11:85PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRefGoogle Scholar
  19. 19.
    Katz A, Nambi SS, Mather K et al (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410PubMedCrossRefGoogle Scholar
  20. 20.
    Dalgard C, Skaalum Petersen M, Weihe P, Grandjean P (2011) Vitamin D status in relation to glucose metabolism and type 2 diabetes in septuagenarians. Diabetes Care 34:1284–1288PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Sun G, Vasdev S, Martin GR, Gadag V, Zhang H (2005) Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and cell function in the new found land population. Diabetes 54:3336–3339PubMedCrossRefGoogle Scholar
  22. 22.
    Aksu NM, Aksoy DY, Akkaş M et al (2013) 25-OH-Vitamin D and procalcitonin levels after correction of acute hyperglycemia. Med Sci Monit 19:264–268PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Zoppini G, Galletti A, Targher G et al (2013) Glycated haemoglobin is inversely related to serum vitamin d levels in type 2 diabetic patients. PLoS One 8:e82733PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E (1997) No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 27:629–633PubMedCrossRefGoogle Scholar
  25. 25.
    Yiu YF, Yiu KH, Siu CW et al (2013) Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227:140–146PubMedCrossRefGoogle Scholar
  26. 26.
    Belenchia AM, Tosh AK, Hillman LS, Peterson CA (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 97:774–781PubMedCrossRefGoogle Scholar
  27. 27.
    Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T (1986) Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner 1:187–192Google Scholar
  28. 28.
    Ulutas O, Taskapan H, Taskapan MC, Temel I (2013) Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients. Int Urol Nephrol 45:879–884PubMedCrossRefGoogle Scholar
  29. 29.
    Sanchez M, de la Sierra A, Coca A, Poch E, Giner V, Urbano-Marquez A (1997) Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension 29:531–536PubMedCrossRefGoogle Scholar
  30. 30.
    Jorde R, Grimnes G (2011) Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 50:303–312PubMedCrossRefGoogle Scholar
  31. 31.
    Ditscheid B, Keller S, Jahreis G (2005) Cholesterol metabolism is affected by calcium phosphate supplementation in humans. J Nutr 135:1678–1682PubMedGoogle Scholar
  32. 32.
    Li K, Kaaks R, Linseisen J, Rohrmann S (2012) Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 98:920–925PubMedCrossRefGoogle Scholar
  33. 33.
    Nikooyeh B, Neyestani TR, Farvid M et al (2011) Daily consumption of vitamin D- or vitamin D+ calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93:764–771PubMedCrossRefGoogle Scholar
  34. 34.
    Zhou J, Zhao LJ, Watson P, Zhang Q, Lappe JM (2010) The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr Metab 7:62CrossRefGoogle Scholar
  35. 35.
    Johnson JA, Grande JP, Roche PC, Kumar R (1994) Immuno histochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol 267:356–360Google Scholar
  36. 36.
    Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG (2003) Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17:509–511PubMedGoogle Scholar
  37. 37.
    Maestro B, Davila N, Carranza MC, Calle C (2003) Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84:223–230PubMedCrossRefGoogle Scholar
  38. 38.
    Sergeev IN, Rhoten WB (1995) 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line. Endocrinology 136:2852–2861PubMedGoogle Scholar
  39. 39.
    Maestro B, Molero S, Bajo S, Davila N, Calle C (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct 20:227–232PubMedCrossRefGoogle Scholar
  40. 40.
    Milner RD, Hales CN (1967) The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 3:47–49PubMedCrossRefGoogle Scholar
  41. 41.
    Beaulieu C, Kestekian R, Havrankova J, Gascon-Barre M (1993) Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes 42:35–43PubMedCrossRefGoogle Scholar
  42. 42.
    Yasuda K, Hurukawa Y, Okuyama M, Kikuchi M, Yoshinaga K (1975) Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release. N Engl J Med 292:501–504PubMedCrossRefGoogle Scholar
  43. 43.
    Jolma P, Kööbi P, Kalliovalkama J et al (2003) Increased calcium intake reduces plasma cholesterol and improves vasorelaxation in experimental renal failure. Am J Physiol Heart Circ Physiol 285:1882–1889Google Scholar
  44. 44.
    Denke MA, Fox MM, Schulte MC (1993) Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 123:1047–1053PubMedGoogle Scholar
  45. 45.
    Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC (2000) Regulation of adiposity by dietary calcium. FASEB J 14:1132–1138PubMedGoogle Scholar
  46. 46.
    Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S (1995) Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8:894–901PubMedCrossRefGoogle Scholar
  47. 47.
    Gerst EM, Rabl W, Rosenbauer J et al (2008) Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 167:447–453CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Marjan Tabesh
    • 1
    • 2
  • Leila Azadbakht
    • 1
    • 2
  • Elham Faghihimani
    • 3
  • Maryam Tabesh
    • 1
  • Ahmad Esmaillzadeh
    • 1
    • 2
    Email author
  1. 1.Food Security Research CenterIsfahan University of Medical SciencesIsfahanIran
  2. 2.Department of Community Nutrition, School of Nutrition and Food ScienceIsfahan University of Medical SciencesIsfahanIran
  3. 3.Isfahan Endocrine and Metabolism Research CenterIsfahan University of Medical SciencesIsfahanIran

Personalised recommendations